Walgreens Boots Alliance Inc (WBA) Shares Bought by Foyston Gordon & Payne Inc

Foyston Gordon & Payne Inc boosted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 358,794 shares of the pharmacy operator’s stock after acquiring an additional 37,006 shares during the period. Walgreens Boots Alliance accounts for approximately 4.8% of Foyston Gordon & Payne Inc’s holdings, making the stock its 6th biggest holding. Foyston Gordon & Payne Inc’s holdings in Walgreens Boots Alliance were worth $27,706,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Bank of Nova Scotia Trust Co. lifted its position in Walgreens Boots Alliance by 31.5% during the third quarter. Bank of Nova Scotia Trust Co. now owns 32,226 shares of the pharmacy operator’s stock valued at $2,488,000 after buying an additional 7,726 shares during the period. Zions Bancorporation lifted its position in Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,239 shares during the period. Capital Bank & Trust Co lifted its position in Walgreens Boots Alliance by 25.8% during the third quarter. Capital Bank & Trust Co now owns 10,078 shares of the pharmacy operator’s stock valued at $778,000 after buying an additional 2,065 shares during the period. Janus Henderson Group PLC lifted its position in Walgreens Boots Alliance by 20.0% during the third quarter. Janus Henderson Group PLC now owns 394,854 shares of the pharmacy operator’s stock valued at $30,476,000 after buying an additional 65,850 shares during the period. Finally, Caxton Associates LP purchased a new position in Walgreens Boots Alliance during the third quarter valued at $641,000. Institutional investors and hedge funds own 61.18% of the company’s stock.

Several equities analysts have commented on WBA shares. Deutsche Bank started coverage on Walgreens Boots Alliance in a research report on Monday, December 4th. They set a “hold” rating and a $78.00 price objective for the company. Raymond James Financial reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, September 27th. Leerink Swann lowered Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 1st. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. Finally, SunTrust Banks set a $72.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Sunday, October 15th. Nine analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $86.15.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $75.38 on Friday. The stock has a market capitalization of $74,600.00, a PE ratio of 20.82, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.10 EPS. equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.59 earnings per share for the current year.

Walgreens Boots Alliance declared that its Board of Directors has initiated a share buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback plans are often an indication that the company’s management believes its stock is undervalued.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Insiders own 14.80% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance Inc (WBA) Shares Bought by Foyston Gordon & Payne Inc” was first published by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another website, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.com-unik.info/2018/01/12/walgreens-boots-alliance-inc-wba-shares-bought-by-foyston-gordon-payne-inc.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit